Sorry, you need to enable JavaScript to visit this website.

CAVERJECT® IMPULSE (alprostadil) Overdosage

10 OVERDOSAGE

Overdosage was not observed in clinical trials with CAVERJECT IMPULSE. If intracavernous overdose of CAVERJECT IMPULSE occurs, the patient should be under medical supervision until any systemic effects have resolved and/or until penile detumescence has occurred. Treatment of any systemic symptoms (e.g., hypotension) would be appropriate.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No